Emerging Infectious Diseases: Preparing for New Global Threats

In recent decades, the emergence of new infectious diseases has underscored how closely global health is interconnected. Outbreaks such as SARS, MERS, Ebola, and more recently COVID-19, have demonstrated the urgent need for rapid, coordinated responses. Today, the pharmaceutical and biotechnology industries are at the forefront of preparing for these new threats, leveraging innovation and advanced technologies to strengthen global resilience.

A constantly evolving world

Emerging infectious diseases are caused by new pathogens or by known microorganisms appearing in new geographic areas or with altered characteristics. Globalization, climate change, urbanization, and the increase in international travel all contribute to their spread. Responding to these challenges requires advanced technology, predictive research, and cross-sector collaboration between science, industry, and health institutions.

The commitment of the pharmaceutical industry

The pharmaceutical industry is investing heavily in research and development to fight emerging infections. New-generation platforms such as mRNA vaccines and viral vector technologies have shown they can drastically accelerate emergency responses. At the same time, artificial intelligence and big data analytics allow for faster epidemiological modeling, improving disease prediction, outbreak management, and treatment development. This technological evolution is transforming pharmaceutical manufacturing, making it more flexible, efficient, and ready to face future global health crises.

Technology serving infection prevention

Effective infection control begins in production environments. Ensuring sterile and contamination-free manufacturing areas is crucial for the safe production of vaccines, biologics, and sterile pharmaceuticals. Automated washing, disinfection, and sterilization systems play a key role in maintaining product quality and patient safety, reducing the risk of contamination throughout the entire production process.

LAST Technology’s contribution

LAST Technology supports the pharmaceutical and biotech industries with innovative sterilization technologies, depyrogenation systems, and cleanroom solutions designed to meet the highest international standards. By optimizing process efficiency and ensuring full regulatory compliance, LAST enables manufacturers to maintain reliable and safe production even in times of public health emergency. Its integrated solutions stand as a vital component of the global infection prevention and pharmaceutical manufacturing network—helping companies stay ready for tomorrow’s challenges.